LEADER 04868nam  2200805Ia 450 
001 9910972573703321
005 20200520144314.0
010   $a9786612889004
010   $a9780470922774
010   $a047092277X
010   $a9781282889002
010   $a1282889001
010   $a9780470910917
010   $a0470910917
010   $a9780470910900
010   $a0470910909
035   $a(CKB)2670000000056431
035   $a(EBL)698802
035   $a(OCoLC)694941437
035   $a(SSID)ssj0000413548
035   $a(PQKBManifestationID)11319705
035   $a(PQKBTitleCode)TC0000413548
035   $a(PQKBWorkID)10383757
035   $a(PQKB)10681637
035   $a(Au-PeEL)EBL698802
035   $a(CaPaEBR)ebr10510325
035   $a(CaONFJC)MIL288900
035   $a(OCoLC)632070275
035   $a(FINmELB)ELB179649
035   $a(MiAaPQ)EBC698802
035   $a(Perlego)1012409
035   $a(EXLCZ)992670000000056431
100   $a20100519d2011      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCardiovascular effects of inhaled ultrafine and nanosized particles /$fedited by Flemming R. Cassee, Nicholas L. Mills, David Newby
205   $a1st ed.
210   $aHoboken, N.J. $cJohn Wiley$dc2011
215   $a1 online resource (608 p.)
300   $aDescription based upon print version of record.
311 08$a9780470433539 
311 08$a0470433531 
320   $aIncludes bibliographical references and index.
327   $aCARDIOVASCULAR EFFECTS OF INHALED ULTRAFINE AND NANOSIZED PARTICLES; CONTENTS; FOREWORD; PREFACE; THE EDITORS; CONTRIBUTORS; PART I: ISSUE FRAMING; CHAPTER 1: OVERVIEW; CHAPTER 2: ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION; CHAPTER 3: CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH; PART II: EXPOSURE; CHAPTER 4: PARTICLE CHARACTERIZATION; CHAPTER 5: EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES; CHAPTER 6: FROM EXPOSURE TO DOSE; CHAPTER 7: TRANSLOCATION OF INHALED NANOPARTICLES
327   $aCHAPTER 8: ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLESPART III: METHODOLOGY; CHAPTER 9: IN VITRO STUDIES; CHAPTER 10: EXPERIMENTAL STUDIES IN ANIMALS; CHAPTER 11: HUMAN EXPOSURE STUDIES; CHAPTER 12: PANEL STUDIES; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS A. ATHEROGENESIS; CHAPTER 13: PARTICULATES AND OXIDATIVE STRESS; CHAPTER 14: ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER; CHAPTER 15: INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS
327   $aCHAPTER 16: INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANSPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS B. VASCULAR DYSFUNCTION; CHAPTER 17: EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE; CHAPTER 18: PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME; CHAPTER 19: PARTICLES AND THE VASCULAR ENDOTHELIUM; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS C. THROMBOSIS; CHAPTER 20: PARTICLES, COAGULATION, AND THROMBOSIS; CHAPTER 21: PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS
327   $aPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS D. ARRHYTHMIACHAPTER 22: PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM; CHAPTER 23: AIR POLLUTION AND ARRHYTHMIA; PART V: ENVIRONMENTAL AND PUBLIC HEALTH POLICY; CHAPTER 24: RISK ASSESSMENT; CHAPTER 25: ENVIRONMENTAL REGULATION OF PARTICULATE MATTER; CHAPTER 26: FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY; INDEX; Color plate
330   $aThis book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions.
606   $aHeart$xToxicology
606   $aAir$xPollution$xToxicology
606   $aNanoparticles$xToxicology
606   $aPulmonary toxicology
615  0$aHeart$xToxicology.
615  0$aAir$xPollution$xToxicology.
615  0$aNanoparticles$xToxicology.
615  0$aPulmonary toxicology.
676   $a616.1/2071
701   $aCassee$b Flemming R$01804445
701   $aMills$b Nicholas L$01804446
701   $aNewby$b David E$01804447
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910972573703321
996   $aCardiovascular effects of inhaled ultrafine and nanosized particles$94352474
997   $aUNINA